Web Site Details Risks of Importing Rx Drugs

Published Online: Monday, August 1, 2005

In recent months, there have been numerous reports by health care experts and security individuals on the risks of importing prescription drugs. The Pharmaceutical Research and Manufacturers of America (PhRMA) is taking action with an online clearinghouse so patients and consumers can learn firsthand about experts' opinions on the dangers associated with importing medicines.

The Web site (www.buysafedrugs. info) provides information on safe, legal ways patients can save money on prescription drugs, educates patients on the risks of importing medicines, and why legalizing importation is a bad policy. "This site will help people understand the wide scope and depth of information that demonstrates [how] importing prescription drugs outside of the FDA delivery system puts patients at risk. It also points patients to safe, legal alternatives to importation if they need help with their prescription drugs," said Billy Tauzin, president and chief executive officer of PhRMA.

To that end, PhRMA formed the Partnership for Prescription Assistance, which offers a single point of access to >275 public and private assistance programs, including >150 programs offered by pharmaceutical companies. For more information, visit www.pparx.org, or call 888-4PPANOW (888-477-2669).

Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues